Yousif Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Sell
120,084
-10,078
-8% -$1.33M 0.17% 95
2026
Q1
$18.1M Sell
130,162
-4,623
-3% -$647K 0.21% 72
2025
Q4
$16.7M Sell
134,785
-5,099
-4% -$620K 0.18% 91
2025
Q3
$15.5M Sell
139,884
-4,999
-3% -$568K 0.17% 107
2025
Q2
$16.1M Sell
144,883
-2,855
-2% -$304K 0.17% 103
2025
Q1
$16.6M Sell
147,738
-3,236
-2% -$334K 0.19% 94
2024
Q4
$13.9M Sell
150,974
-3,134
-2% -$282K 0.15% 112
2024
Q3
$12.9M Sell
154,108
-2,083
-1% -$159K 0.14% 132
2024
Q2
$10.7M Sell
156,191
-4,996
-3% -$333K 0.12% 147
2024
Q1
$11.8M Sell
161,187
-8,300
-5% -$638K 0.13% 142
2023
Q4
$13.7M Sell
169,487
-25,117
-13% -$1.95M 0.16% 113
2023
Q3
$14.6M Sell
194,604
-38,956
-17% -$3M 0.19% 95
2023
Q2
$18M Sell
233,560
-8,512
-4% -$679K 0.22% 74
2023
Q1
$20.1M Sell
242,072
-8,934
-4% -$740K 0.26% 62
2022
Q4
$21.5M Buy
251,006
+10,965
+5% +$868K 0.28% 60
2022
Q3
$14.8M Sell
240,041
-11,160
-4% -$704K 0.21% 81
2022
Q2
$15.5M Buy
251,201
+12,170
+5% +$753K 0.2% 79
2022
Q1
$14.2M Buy
239,031
+6,654
+3% +$425K 0.15% 111
2021
Q4
$16.9M Buy
+232,377
New +$16M 0.17% 95

Other funds holding GILD

Yousif Capital Management's GILD Position: Q2 2026 in Review

Yousif Capital Management reduced its Gilead Sciences (GILD) stake by 7.7% in Q2 2026, selling an estimated $1.33M and leaving 120,084 shares worth $15.2M. The position accounts for 0.17% of the portfolio, ranked #95.

Yousif Capital Management first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $21.5M in Q4 2022. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Yousif Capital Management held 120,084 shares of Gilead Sciences worth $15.2M as of Q2 2026.
  • Yousif Capital Management sold 10,078 Gilead Sciences shares in Q2 2026, an estimated $1.33M.
  • Gilead Sciences made up 0.17% of Yousif Capital Management's portfolio in Q2 2026, its #95 holding.
  • Yousif Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Gilead Sciences position peaked at $21.5M in Q4 2022.
  • 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.